EANM/SNMMI guideline/procedure standard for [18F]FDG hybrid PET use in infection and inflammation in adults v2.0

Gespeichert in:
Bibliographische Detailangaben
Titel: EANM/SNMMI guideline/procedure standard for [18F]FDG hybrid PET use in infection and inflammation in adults v2.0
Autoren: Gad Abikhzer, Giorgio Treglia, Matthieu Pelletier-Galarneau, John Buscombe, Arturo Chiti, Elizabeth H. Dibble, Andor W. J. M. Glaudemans, Christopher J. Palestro, Mike Sathekge, Alberto Signore, Francois Jamar, Ora Israel, Olivier Gheysens
Weitere Verfasser: Apollo - University of Cambridge Repository
Quelle: Eur J Nucl Med Mol Imaging
European journal of nuclear medicine and molecular imaging, vol. 52, no. 2, pp. 510-538
Verlagsinformationen: Springer Science and Business Media LLC, 2024.
Publikationsjahr: 2024
Schlagwörter: Inflammation, Adult, SDG-03: Good health and well-being, SDG-09: Industry, PET/CT, Humans, Fluorodeoxyglucose F18, Inflammation/diagnostic imaging, Nuclear Medicine/standards, Positron-Emission Tomography/standards, Positron-Emission Tomography/methods, Infections/diagnostic imaging, Societies, Medical, Guideline, Infection, Procedure standard, [18F]FDG, Infammation, Infections, Positron emission tomography/computed tomography (PET/CT), Positron-Emission Tomography, Original Article, F]FDG, Nuclear Medicine, Radiopharmaceuticals, [, innovation and infrastructure
Beschreibung: Introduction Hybrid [18F]FDG PET imaging is currently the method of choice for a wide variety of infectious and inflammatory disorders and was recently adopted in several clinical guidelines. A large amount of evidence-based articles, guidelines and appropriate use criteria have been published since the first version of this guideline in 2013. Purpose To provide updated evidence-based information to assist physicians in recommending, performing and interpreting hybrid [18F]FDG PET examinations for infectious and inflammatory disorders in the adult population. Methods A systematic literature search of evidence-based articles using whole-body [18F]FDG hybrid imaging on the indications covered within this guideline was performed. All systematic reviews and meta-analyses published within the last 10 years until January 2023 were identified in PubMed/Medline or Cochrane. For each indication covered in this manuscript, diagnostic performance was provided based on meta-analyses or systematic reviews. If not available, results from prospective or retrospective studies were considered based on predefined selection criteria. Results and conclusions Hybrid [18F]FDG PET is extremely useful in the work-up and management of adults with infectious and inflammatory diseases, as supported by extensive and rapidly growing evidence-based literature and adoption in clinical guidelines. Practical recommendations are provided describing evidence-based indications as well as interpretation criteria and pitfalls. Monitoring treatment response is the most challenging but insufficiently studied potential application in infection and inflammation imaging.
Publikationsart: Article
Other literature type
Dateibeschreibung: application/pdf; application/zip; text/xml; application/vnd.openxmlformats-officedocument.wordprocessingml.document
Sprache: English
ISSN: 1619-7089
1619-7070
DOI: 10.1007/s00259-024-06915-3
Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/39387894
https://serval.unil.ch/notice/serval:BIB_A8C1DE22279E
https://serval.unil.ch/resource/serval:BIB_A8C1DE22279E.P001/REF.pdf
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_A8C1DE22279E2
Rights: CC BY
Dokumentencode: edsair.doi.dedup.....9fccc8d7ef30c3887d79366d2b462e7a
Datenbank: OpenAIRE
Beschreibung
Abstract:Introduction Hybrid [18F]FDG PET imaging is currently the method of choice for a wide variety of infectious and inflammatory disorders and was recently adopted in several clinical guidelines. A large amount of evidence-based articles, guidelines and appropriate use criteria have been published since the first version of this guideline in 2013. Purpose To provide updated evidence-based information to assist physicians in recommending, performing and interpreting hybrid [18F]FDG PET examinations for infectious and inflammatory disorders in the adult population. Methods A systematic literature search of evidence-based articles using whole-body [18F]FDG hybrid imaging on the indications covered within this guideline was performed. All systematic reviews and meta-analyses published within the last 10 years until January 2023 were identified in PubMed/Medline or Cochrane. For each indication covered in this manuscript, diagnostic performance was provided based on meta-analyses or systematic reviews. If not available, results from prospective or retrospective studies were considered based on predefined selection criteria. Results and conclusions Hybrid [18F]FDG PET is extremely useful in the work-up and management of adults with infectious and inflammatory diseases, as supported by extensive and rapidly growing evidence-based literature and adoption in clinical guidelines. Practical recommendations are provided describing evidence-based indications as well as interpretation criteria and pitfalls. Monitoring treatment response is the most challenging but insufficiently studied potential application in infection and inflammation imaging.
ISSN:16197089
16197070
DOI:10.1007/s00259-024-06915-3